Back to search

University of British Columbia

Metal chelating agents for medicinal radionuclides

Abstract

dc:description

Medical radionuclides can be classified into non-metallic and metallic. Due to the much broader decay spectrum, radiometal ions are generally of greater interest in radiopharmaceutical designs. Since free radionuclides are rapidly taken up by the non-targeting organs/tissues such as bone, liver and kidney, causing unnecessary radiation burden to the body, they need to be stably coordinated by a suitable bifunctional chelator conjugated to a biological targeting vector, which directs the radiation doses specifically to the tumor site. This thesis describes several picolinate-based ligand scaffolds (H4octapa, H4pypa and H4py4pa) with denticity from eight to eleven to accommodate radionuclides as small as scandium-44 and as large as actinium-225. Apart from rapid and stable chelation, versatile bifunctionalization is a crucial but often under-valued property of a ligand. The chemical properties of the linker can significantly alter the biodistribution of the chelate-bioconjugate, while the position of the linker in the ligand can dictate the coordination geometry. The second effect was observed in two newly developed 177Lu-labeled H4octapa peptide conjugates discussed in this thesis. This observation prompted the development of two functionally versatile chelators, H4pypa and H4py4pa, with increased rigidity imposed by the central pyridyl moiety that connects the pendent chelating arms. The central pyridyl moiety also serve as a convenient and robust bioconjugation spot. Studies of H4pypa with scandium-44, lutetium-177, indium-111, yttrium-86, zirconium-89, and H4py4pa with actinium-225 were conducted, while their biological properties were evaluated with either the peptide- or the antibody-conjugates, showing favorable radiolabeling results and stability which even surpassed the current “gold-standard” chelator, DOTA, rendering them highly promising for the applications in nuclear medicine.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy - PhD
Level thesis:degree_level
doctoral
Discipline thesis:degree_discipline
Chemistry
Grantor dc:publisher
University of British Columbia
Year dc:date
2020

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Li, Lily

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/75076

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Li, Lily. Metal chelating agents for medicinal radionuclides. doctoral thesis, University of British Columbia, 2020. http://hdl.handle.net/2429/75076